Vyant Bio
(NASDAQ) VYNT
Vyant Bio Financials at a Glance
Market Cap
N/A
Revenue (TTM)
$666.00K
Net Income (TTM)
$28.71M
EPS (TTM)
N/A
P/E Ratio
N/A
Dividend
N/A
Beta (Volatility)
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
Dividend
N/A
Beta (Volatility)
N/A
Price
N/A
Volume
N/A
Open
N/A
Previous Close
N/A
Daily Range
N/A
52-Week Range
N/A
VYNT News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Vyant Bio
Industry
Biotechnology
Sector
Health CareEmployees
8
CEO
John A. Roberts, MBA
Website
www.vyantbio.comHeadquarters
Cherry Hill, NJ 08002, US
VYNT Financials
Key Financial Metrics (TTM)
Gross Margin
-51%
Operating Margin
-24%
Net Income Margin
-34%
Return on Equity
-1%
Return on Capital
-1%
Return on Assets
-1%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
N/A
Shares Outstanding
N/A
Volume
N/A
Short Interest
N/A
Avg. Volume
N/A
Financials (TTM)
Gross Profit
$342.00K
Operating Income
$15.91M
EBITDA
$14.87M
Operating Cash Flow
$13.68M
Capital Expenditure
$617.00K
Free Cash Flow
$14.30M
Cash & ST Invst.
$10.04M
Total Debt
$2.20M
Vyant Bio Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$46.00K
+101.8%
Gross Profit
$15.00K
+98.6%
Gross Margin
-32.61%
N/A
Market Cap
N/A
N/A
Market Cap/Employee
N/A
N/A
Employees
4
N/A
Net Income
$10.31M
+58.5%
EBITDA
$3.17M
-20.4%
Quarterly Fundamentals
Net Cash
$7.84M
-59.6%
Accounts Receivable
$323.00K
-25.6%
Inventory
$53.00K
-88.8%
Long Term Debt
$1.63M
+88.3%
Short Term Debt
$565.00K
+70.7%
Return on Assets
-1.49%
N/A
Return on Invested Capital
-1.38%
N/A
Free Cash Flow
$3.30M
-9.4%
Operating Cash Flow
$3.29M
-9.6%